Arbutus Biopharma Corporation

ABUS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 27, 2026 8-K
SCHEDULE 13G/A May 15, 2026
10-Q May 13, 2026 10-Q
8-K May 13, 2026 FORM 8-K
SCHEDULE 13D/A Apr 28, 2026
8-K Apr 15, 2026 FORM 8-K
DEFA14A Apr 14, 2026 DEFA14A
DEF 14A Apr 14, 2026 DEF 14A
SCHEDULE 13D/A Apr 13, 2026
8-K Mar 23, 2026 FORM 8-K
10-K Mar 23, 2026 10-K
8-K Mar 3, 2026 FORM 8-K
8-K Feb 20, 2026 FORM 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Feb 11, 2026
8-K Feb 6, 2026 FORM 8-K
4 Feb 2, 2026 FORM 4
4 Feb 2, 2026 FORM 4
8-K Jan 16, 2026 FORM 8-K
8-K Dec 11, 2025 FORM 8-K
8-K Nov 13, 2025 FORM 8-K
10-Q Nov 13, 2025 10-Q
8-K Oct 7, 2025 FORM 8-K
8-K Sep 10, 2025 FORM 8-K
SCHEDULE 13G Aug 13, 2025
← Newer Page 2 of 42 · 1047 filings Older →